Username or e-mail:
*
Password:
*
Forgot Password?
British Columbia Drug and Poison Information Centre (BC DPIC)
Healthcare Professionals
Health Headlines
Weblinks
About DPIC
Contact
Terms & Conditions
Index
Search this site:
Poison Information
24-Hour Line:
1-800-567-8911 or
604-682-5050
General Information
Prevention Tips
Prevention Material
Fact Sheets
BC Poison Control
Springtime Hazards
Holiday Hazards
Poison FAQ
Drug Information
BC Healthcare Professionals
Drug Information Line
1-866-298-5909 or
604-707-2787
(Mon - Fri, 9am to 4pm)
Clinical Practice Guidelines
Drug Product Listings
Safe Medication Use
Publications
DI Perpectives Newsletter
Drug Desk Newsletter
Drug Information Reference
Home
›
Drug Product Listings
› Trabectedin
Trabectedin
Trade Name:
Yondelis
Manufacturer/Distributor:
Ortho Biotech
1-800-567-3331
Classification:
Antineoplastic agent
ATC Class:
L01CX01
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/05/13
Date Marketed in Canada (yyyy/mm/dd):
2010/08/04
Presentation:
Injection: 1 mg/vial; DIN 02351528
Comments:
For treatment of ovarian cancer (in combination with pegylated liposmal doxorubicin) in patients who have failed or will not benefit from platinum-based chemotherapy.
Posted
Updated
2010-08-05 09:59
2010-08-05 10:05
Back to:
Drug Product Listings
Browse by keywords:
ovarian neoplasms
trabectedin
-
A
+
A
Follow DPIC
Facebook
Twitter